.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Chubb
Johnson and Johnson
McKinsey
Medtronic
UBS
Deloitte
Novartis
Merck
Healthtrust

Generated: July 23, 2017

DrugPatentWatch Database Preview

Hospira Inc Company Profile

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?

HOSPIRA INC has seventy-eight approved drugs.

There are four tentative approvals on HOSPIRA INC drugs.

Summary for Applicant: Hospira Inc

Patents:0
Tradenames:59
Ingredients:48
NDAs:78
Drug Master File Entries: (click here to view)31
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
PIPERACILLIN AND TAZOBACTAM
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION065386-001Sep 15, 2009APRXNoNo► Subscribe► Subscribe
Hospira Inc
ZOLEDRONIC ACID
zoledronic acid
SOLUTION;IV (INFUSION)204016-001Dec 28, 2015RXNoNo► Subscribe► Subscribe
Hospira Inc
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE;INJECTION203884-001Nov 25, 2013APRXNoNo► Subscribe► Subscribe
Hospira Inc
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
INJECTABLE;INJECTION075409-001Jun 20, 2000DISCNNoNo► Subscribe► Subscribe
Hospira Inc
CEFEPIME HYDROCHLORIDE
cefepime hydrochloride
INJECTABLE;INJECTION065369-002Jun 18, 2007APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira Inc
NIPENT
pentostatin
INJECTABLE;INJECTION020122-001Oct 11, 19913,923,785► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for HOSPIRA INC drugs

Drugname Dosage Strength Tradename Submissiondate
argatroban in sodium chloride
Injection1 mg/mL, 50 mL vials
ARGATROBAN
12/16/2011
argatroban
Injection100 mg/mL, 2.5 mL vials
ARGATROBAN
9/24/2007

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Federal Trade Commission
Merck
US Army
Fuji
Boehringer Ingelheim
Argus Health
Accenture
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot